Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/29535
Title: | Body surface area-based vs concentration-based perioperative intraperitoneal chemotherapy after optimal cytoreductive surgery in colorectal peritoneal surface malignancy treatment: COBOX trial | Authors: | LEMOINE, Lieselotte THIJSSEN, Elsy CARLEER, Robert Geboers, Karlien Sugarbaker, Paul VAN DER SPEETEN, Kurt |
Issue Date: | 2019 | Publisher: | WILEY | Source: | JOURNAL OF SURGICAL ONCOLOGY, 119(7), p. 999-1010 | Abstract: | Background and ObjectivesCytoreductive surgery (CRS) and hyperthermic intraperitoneal perioperative chemotherapy (HIPEC) are the standard of care for patients diagnosed with colorectal peritoneal surface malignancy (PSM). Despite a clearly defined standardization of CRS, a large variety of HIPEC modalities are still used in clinical practice. MethodsBody surface area (BSA)- and concentration-based HIPEC protocols were clinically and pharmacologically evaluated in a randomized phase III clinical pilot trial. Oxaliplatin dose was 460mg/m (2) (BSA-based) in 2L/m (2) carrier solution (concentration-based). Platinum quantification was performed using a validated inductively coupled plasma mass spectrometry method. Three-month morbidity, mortality, and health-related quality of life (HRQOL) were assessed. ResultsThirty-one patients were randomized to either BSA- or concentration-based HIPEC. Toxicity and efficacy were higher (P<0.001) in patients receiving concentration-based HIPEC. There was no difference in pharmacologic advantage between the two groups. A higher drug concentration in the tumor nodule at the end of HIPEC was found in the HIPEC-concentration group. There was no difference in major morbidity and mortality between the treatment groups. HRQOL was decreased 3 months postoperatively in the HIPEC-concentration group. ConclusionConcentration-based chemotherapy delivers the drug in the most standardized way to the tumor nodule, resulting in increasing drug concentrations in the tumor nodule without increasing major morbidity. | Notes: | [Lemoine, Lieselotte; Geboers, Karlien; van der Speeten, Kurt] Hasselt Univ, Dept Med & Life Sci, Hasselt, Belgium. [Lemoine, Lieselotte; van der Speeten, Kurt] Ziekenhuis Oost Limburg, Dept Surg Oncol, Campus Sint Jan,Schiepse Bos 6, B-3600 Genk, Belgium. [Thijssen, Elsy; Carleer, Robert] Hasselt Univ, Inst Mat Res, Appl & Analyt Chem, Diepenbeek, Belgium. [Sugarbaker, Paul] MedStar Washington Hosp Ctr, Ctr Gastrointestinal Malignancies, Washington, DC USA. | Keywords: | body surface area‐based, colorectal peritoneal surface malignancy, concentration‐based,hyperthermic intraperitoneal perioperative chemotherapy, oxaliplatin;body surface area-based; colorectal peritoneal surface malignancy; concentration-based; hyperthermic intraperitoneal perioperative chemotherapy; oxaliplatin | Document URI: | http://hdl.handle.net/1942/29535 | ISSN: | 0022-4790 | e-ISSN: | 1096-9098 | DOI: | 10.1002/jso.25437 | ISI #: | 000476938900024 | Rights: | 2019 Wiley Periodicals, Inc. | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2020 |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
lemoine 1.pdf Restricted Access | Published version | 748.29 kB | Adobe PDF | View/Open Request a copy |
SCOPUSTM
Citations
5
checked on Sep 3, 2020
WEB OF SCIENCETM
Citations
20
checked on Apr 22, 2024
Page view(s)
98
checked on Aug 9, 2022
Download(s)
82
checked on Aug 9, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.